Lead the charge in clinical development for neurodegenerative therapies, collaborating with cross-functional teams to design, execute, and oversee pivotal trials while ensuring regulatory compliance to improve patient outcomes.

Lead the charge in advancing innovative neuroscience programs, driving scientific excellence with a focus on preclinical pharmacology, biomarker development, and clinical strategies to tackle severe neurologic disorders and enhance therapeutic outcomes.